ResMed Other Long-Term Assets 2010-2024 | RMD
ResMed other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- ResMed other long-term assets for the quarter ending September 30, 2024 were $0.279B, a 5.18% increase year-over-year.
- ResMed other long-term assets for 2024 were $0.284B, a 8.21% increase from 2023.
- ResMed other long-term assets for 2023 were $0.262B, a 52.81% increase from 2022.
- ResMed other long-term assets for 2022 were $0.172B, a 6.73% increase from 2021.
| ResMed Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $284 |
| 2023 | $262 |
| 2022 | $172 |
| 2021 | $161 |
| 2020 | $149 |
| 2019 | $151 |
| 2018 | $274 |
| 2017 | $42 |
| 2016 | $38 |
| 2015 | $28 |
| 2014 | $17 |
| 2013 | $6 |
| 2012 | $8 |
| 2011 | $12 |
| 2010 | $5 |
| 2009 | $5 |
| ResMed Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $279 |
| 2024-06-30 | $284 |
| 2024-03-31 | $277 |
| 2023-12-31 | $276 |
| 2023-09-30 | $265 |
| 2023-06-30 | $262 |
| 2023-03-31 | $271 |
| 2022-12-31 | $260 |
| 2022-09-30 | $173 |
| 2022-06-30 | $172 |
| 2022-03-31 | $169 |
| 2021-12-31 | $166 |
| 2021-09-30 | $163 |
| 2021-06-30 | $161 |
| 2021-03-31 | $150 |
| 2020-12-31 | $157 |
| 2020-09-30 | $146 |
| 2020-06-30 | $149 |
| 2020-03-31 | $141 |
| 2019-12-31 | $164 |
| 2019-09-30 | $141 |
| 2019-06-30 | $151 |
| 2019-03-31 | $126 |
| 2018-12-31 | $138 |
| 2018-09-30 | $117 |
| 2018-06-30 | $274 |
| 2018-03-31 | $176 |
| 2017-12-31 | $42 |
| 2017-09-30 | $44 |
| 2017-06-30 | $42 |
| 2017-03-31 | $46 |
| 2016-12-31 | $43 |
| 2016-09-30 | $41 |
| 2016-06-30 | $38 |
| 2016-03-31 | $41 |
| 2015-12-31 | $38 |
| 2015-09-30 | $35 |
| 2015-06-30 | $28 |
| 2015-03-31 | $29 |
| 2014-12-31 | $28 |
| 2014-09-30 | $18 |
| 2014-06-30 | $17 |
| 2014-03-31 | $12 |
| 2013-12-31 | $8 |
| 2013-09-30 | $5 |
| 2013-06-30 | $6 |
| 2013-03-31 | $5 |
| 2012-12-31 | $4 |
| 2012-09-30 | $6 |
| 2012-06-30 | $8 |
| 2012-03-31 | $12 |
| 2011-12-31 | $14 |
| 2011-09-30 | $8 |
| 2011-06-30 | $12 |
| 2011-03-31 | $12 |
| 2010-12-31 | $8 |
| 2010-09-30 | $7 |
| 2010-06-30 | $5 |
| 2010-03-31 | $5 |
| 2009-12-31 | $6 |
| 2009-09-30 | $6 |
| 2009-06-30 | $5 |
| 2009-03-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $35.759B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.382B | 25.94 |
| Stryker (SYK) | United States | $148.728B | 33.52 |
| Boston Scientific (BSX) | United States | $134.855B | 38.77 |
| EssilorLuxottica (ESLOY) | France | $111.549B | 0.00 |
| Medtronic (MDT) | Ireland | $108.676B | 16.14 |
| Haleon (HLN) | United Kingdom | $43.230B | 28.09 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.368B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.464B | 19.43 |
| Terumo (TRUMY) | Japan | $29.367B | 41.47 |
| Koninklijke Philips (PHG) | Netherlands | $24.796B | 18.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.580B | 13.74 |
| Insulet (PODD) | United States | $18.378B | 73.18 |
| Baxter (BAX) | United States | $16.844B | 10.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.947B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.886B | 39.63 |
| Bio-Rad Laboratories (BIO) | United States | $9.115B | 30.98 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.071B | 14.11 |
| TG Therapeutics (TGTX) | United States | $5.378B | 0.00 |
| Haemonetics (HAE) | United States | $4.291B | 20.94 |
| Prestige Consumer Healthcare (PBH) | United States | $4.157B | 20.67 |
| ICU Medical (ICUI) | United States | $4.134B | 39.36 |
| Perrigo (PRGO) | Ireland | $3.694B | 10.88 |
| Envista Holdings (NVST) | United States | $3.681B | 27.42 |
| Agios Pharmaceuticals (AGIO) | United States | $3.167B | 0.00 |
| Neogen (NEOG) | United States | $3.159B | 36.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.782B | 17.84 |
| QuidelOrtho (QDEL) | United States | $2.548B | 16.40 |
| LeMaitre Vascular (LMAT) | United States | $2.380B | 57.85 |
| Warby Parker (WRBY) | United States | $2.366B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.977B | 34.59 |
| AtriCure (ATRC) | United States | $1.740B | 0.00 |
| InMode (INMD) | Israel | $1.552B | 9.34 |
| AdaptHealth (AHCO) | United States | $1.331B | 9.51 |
| Curaleaf Holdings (CURLF) | Canada | $1.293B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.253B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.178B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.97 |
| Owens & Minor (OMI) | United States | $0.943B | 7.37 |
| National Vision Holdings (EYE) | United States | $0.910B | 30.40 |
| CeriBell (CBLL) | United States | $0.904B | 0.00 |
| Evolus (EOLS) | United States | $0.826B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.809B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.679B | 30.02 |
| Surmodics (SRDX) | United States | $0.561B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.561B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.554B | 0.00 |
| Quanterix (QTRX) | United States | $0.450B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.407B | 0.00 |
| ZimVie (ZIMV) | United States | $0.379B | 31.95 |
| Valneva SE (VALN) | France | $0.359B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.339B | 32.26 |
| Biote (BTMD) | United States | $0.334B | 7.31 |
| Sanara MedTech (SMTI) | United States | $0.326B | 0.00 |
| Cerus (CERS) | United States | $0.310B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.287B | 19.25 |
| Zynex (ZYXI) | United States | $0.258B | 54.07 |
| Aurora Cannabis (ACB) | Canada | $0.236B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.224B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.12 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| MacroGenics (MGNX) | United States | $0.201B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.189B | 2.67 |
| Jin Medical (ZJYL) | China | $0.166B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.164B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 98.40 |
| Zevia PBC (ZVIA) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.50 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.75 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.10 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.079B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.071B | 36.67 |
| Exagen (XGN) | United States | $0.069B | 0.00 |
| Modular Medical (MODD) | United States | $0.067B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.053B | 0.00 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.033B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.83 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |